Free Trial

Owens & Minor (OMI) Competitors

Owens & Minor logo
$7.25 +0.10 (+1.40%)
As of 03:59 PM Eastern

OMI vs. MCK, COR, CAH, HSIC, PDCO, VCYT, AMRX, DNLI, BCRX, and BHVN

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Veracyte (VCYT), Amneal Pharmaceuticals (AMRX), Denali Therapeutics (DNLI), BioCryst Pharmaceuticals (BCRX), and Biohaven (BHVN). These companies are all part of the "medical" sector.

Owens & Minor vs.

Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings.

McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.70B0.05-$41.30M-$4.75-1.49
McKesson$344.58B0.25$3.00B$21.8431.61

Owens & Minor has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, McKesson has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.

McKesson received 720 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.24% of users gave McKesson an outperform vote while only 48.04% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
257
48.04%
Underperform Votes
278
51.96%
McKessonOutperform Votes
977
74.24%
Underperform Votes
339
25.76%

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Owens & Minor currently has a consensus price target of $12.50, suggesting a potential upside of 76.06%. McKesson has a consensus price target of $686.69, suggesting a potential downside of 0.52%. Given Owens & Minor's higher possible upside, research analysts plainly believe Owens & Minor is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
McKesson
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87

In the previous week, McKesson had 39 more articles in the media than Owens & Minor. MarketBeat recorded 64 mentions for McKesson and 25 mentions for Owens & Minor. McKesson's average media sentiment score of 1.11 beat Owens & Minor's score of 0.75 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
6 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
McKesson
34 Very Positive mention(s)
5 Positive mention(s)
14 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.46% 14.60% 2.51%
McKesson 0.82%-181.26%5.34%

Summary

McKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks.

Get Owens & Minor News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$553.53M$8.00B$5.43B$19.40B
Dividend YieldN/A1.98%5.44%3.95%
P/E Ratio-11.0221.7525.6534.59
Price / Sales0.051.17405.2634.72
Price / Cash1.2510.7638.3117.51
Price / Book0.592.156.724.70
Net Income-$41.30M$259.21M$3.23B$1.02B
7 Day Performance-8.15%-1.21%2.66%4.31%
1 Month Performance2.90%3.89%10.86%10.92%
1 Year Performance-62.05%-7.78%15.50%6.01%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMI
Owens & Minor
4.787 of 5 stars
$7.25
+1.4%
$12.50
+72.4%
-61.6%$560.10M$10.70B-11.1522,500Earnings Report
Analyst Revision
MCK
McKesson
4.4087 of 5 stars
$706.68
-0.2%
$681.00
-3.6%
+22.7%$88.57B$344.58B32.3675,000Earnings Report
Analyst Revision
Positive News
COR
Cencora
4.6389 of 5 stars
$291.80
-0.1%
$290.00
-0.6%
+23.9%$56.58B$638.56M41.5142,000Earnings Report
Dividend Announcement
Positive News
CAH
Cardinal Health
4.6948 of 5 stars
$151.73
+1.5%
$146.43
-3.5%
+49.2%$36.65B$222.28B28.3146,500Positive News
HSIC
Henry Schein
3.1474 of 5 stars
$66.58
+2.0%
$80.20
+20.5%
-3.9%$8.16B$12.67B27.4022,000
PDCO
Patterson Companies
1.9891 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700
VCYT
Veracyte
3.8971 of 5 stars
$31.32
+3.2%
$42.60
+36.0%
+43.9%$2.45B$445.76M-208.80790
AMRX
Amneal Pharmaceuticals
3.0094 of 5 stars
$7.54
-5.4%
$10.80
+43.2%
+14.1%$2.34B$2.79B-11.097,600Analyst Downgrade
Positive News
DNLI
Denali Therapeutics
4.4057 of 5 stars
$15.99
-2.7%
$37.57
+135.0%
-19.2%$2.32B$330.53M-5.79430Earnings Report
Analyst Revision
News Coverage
BCRX
BioCryst Pharmaceuticals
4.6836 of 5 stars
$11.03
+23.5%
$16.13
+46.2%
+94.4%$2.31B$450.71M-18.08530High Trading Volume
BHVN
Biohaven
3.6485 of 5 stars
$22.59
-1.1%
$62.54
+176.8%
-42.7%$2.31BN/A-2.42239Earnings Report
Analyst Forecast

Related Companies and Tools


This page (NYSE:OMI) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners